Abraxane paclitaxel: Phase I data

Data from an open-label, U.S. Phase I trial in 39 patients showed that the MTDs of ABI-007 were 100 and 150 mg/m 2 for lightly and heavily pretreated patients, respectively. Patients received an avera...